Main Article Content

Immunomodulation of IFN-ã, IL-4, and IL-10 Cytokines by Polyherbal Formulation in Cyclophosphamide-Induced Immunosuppression among Wistar Rats


K.M. Hamid
N.K. Abubakar
M.H. Yeldu
M.I. Abdullahi
A.B. Usman
S.Y. Isah
M. Aliyu

Abstract

This study evaluated the immunomodulatory potential of aqueous extract of polyherbal formulation (PHF) in cyclophosphamide (CP)- induced immunosuppression in Wistar albino rats. The rats were randomly divided into six (6) groups of four (4) rats each. The normal control group received 10 ml/kg b.w of normal saline for 28 days orally. The Positive control group received 50mg/kg b.w of Levamisole Hydrochloride for 28 days orally.  Cyclophosphamide (CP) control group had 10 mg/ kg b.w of CP for three days subcutaneously.  While the Treatment control group received 1500 mg/ kg b.w of PHF orally for 28 days. Treatment 1 group received 10 mg/ kg b.w of CP for three days subcutaneously, followed by oral administration of 1500 mg/ kg b.w of PHF for 28 days.  Lastly, Treatment 2 group received 1500 mg/ kg b.w of PHF for 28 days orally, followed by subcutaneous administration of 10 mg/ kg b.w of CP for three days. On the first day prior to any intervention, 1 ml of the blood sample was collected from each rat which serve as a pre-treatment sample. At the end of the experiment (after 28 days), a blood sample was collected from each rat which serve as a post-treatment sample. The serum concentration of IFN-ã, IL-4, and IL-10 were determined using the ELISA technique. For pre-treatment samples, there was no statistically significant difference in the mean serum concentration of the cytokines across the groups (p >0.05). For post-treatment samples, there was a statistically significant difference in the mean serum concentration of IFN-ã (p < 0.0001) and IL-4 (p<0.001) across the groups. There was a significant difference when normal controls were compared with other groups in IFN-ã and IL-4 (p <0.05). No significant difference was observed in IL-10. The formulation seems to neutralise the immunosuppressive condition and induce immunostimulatory activity on the immune cells responsible for the secretion of IFN-ã and IL-4.


Journal Identifiers


eISSN:
print ISSN: 2536-7153